Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v5-EN Version v1-EN
Language English English
Date Updated 2018-08-09 2018-06-05
Drug Identification Number 02443686 02443686
Brand name BUPIVACAINE INJECTION BP BUPIVACAINE INJECTION BP
Common or Proper name BUPIVACAINE INJECTION BP BUPIVACAINE INJECTION BP
Company Name STERIMAX INC STERIMAX INC
Ingredients BUPIVACAINE HYDROCHLORIDE BUPIVACAINE HYDROCHLORIDE
Strength(s) 2.5MG 2.5MG
Dosage form(s) SOLUTION SOLUTION
Route of administration BLOCK/INFILTRATION EPIDURAL BLOCK/INFILTRATION EPIDURAL
Packaging size 10 VIALS 10 VIALS
ATC code N01BB N01BB
ATC description ANESTHETICS, LOCAL ANESTHETICS, LOCAL
Reason for shortage Delay in shipping of the drug. Delay in shipping of the drug.
Anticipated start date
Actual start date 2018-06-01 2018-06-01
Estimated end date 2018-06-22 2018-06-22
Actual end date 2018-08-08
Shortage status Resolved Actual shortage
Company comments Product is on 100% allocation. Product is on 100% allocation.
Health Canada comments